Justilien and colleagues revealed the co-amplification of two oncogenes, PRKCI and SOX2, is responsible for the cancer stem cell phenotype seen in lung squamous cell carcinoma (LSCC) [61]. The gene discussed is SOX2; the disease is cancer.